MBS524 - Creating the next wave of cancer therapeutics - Charles Theuer, CEO TraconPharma.com (Built in California #33)

Matt Brown Show - Telling the stories of influencers and business thought leaders, one conversation at a time

English - December 09, 2022 22:00 - 44 minutes - 30.5 MB - ★★★★ - 4 ratings
Business business entrepreneurships technology authors startups business news crypto Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: MBS523 - How to disrupt a $850 Billion aerospace industry - David Bettenhausen, CEO Aerotrax (Built in Texas #12)

Next Episode: MBS528 - The next generation of psychedelic therapeutics, Chad Harman, CEO Psycheceutical (Built in Texas #13)

TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, Our lead product candidate, envafolimab, is a PD-L1 antibody that is being developed for the treatment of sarcoma. Our other product candidates are YH001, a CTLA-4 antibody that is in Phase 1/2 development for the treatment of sarcoma, TRC102, a small molecule that is in Phase 2 clinical development for the treatment of mesothelioma; TJ004309, a CD73 antibody that is in Phase 1 testing, that is being developed through a collaboration with I-Mab Biopharma; multiple bispecific antibody programs in preclinical development that are being developed through a collaboration with I-Mab Biopharma.

Get interviewed on the Matt Brown Show: www.mattbrownshow.com

Support the Show.